Bellevue Life Sciences Acquisition Corp. Warrant

Financial Services US BLACW

NoneUSD
-(-%)

Last update at 2025-03-13T21:00:59.526158Z

Day Range

--
LowHigh

52 Week Range

0.010.06
LowHigh

Fundamentals

  • Previous Close 0.05
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Income before tax 0.94M -0.03539M -0.00331M
Minority interest - - -
Net income 0.40M -0.03539M -0.00331M
Selling general administrative 1.83M 0.04M 0.00331M
Selling and marketing expenses - - -
Gross profit - - -
Reconciled depreciation - - -
Ebit - -0.03539M -0.00331M
Ebitda - - -
Depreciation and amortization - - -
Non operating income net other - - -
Operating income -1.83070M -0.03539M -0.00331M
Other operating expenses - - -
Interest expense - - -
Tax provision 0.54M 0.00000M -
Interest income 2.78M 0.00000M -
Net interest income 2.78M 0.00000M -
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense - - -
Total revenue 0.00000M 0.00000M 0.00000M
Total operating expenses 1.83M 0.04M 0.00331M
Cost of revenue - - -
Total other income expense net - - -
Discontinued operations - - -
Net income from continuing ops 0.40M -0.03539M -0.00331M
Net income applicable to common shares - - -
Preferred stock and other adjustments - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 36.63M 1.23M 0.71M 0.32M
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab 4.11M 1.26M 0.71M 0.32M
Total stockholder equity 32.52M -0.03751M -0.00212M 0.00119M
Deferred long term liab - - - -
Other current liab - - - -
Common stock - - - -
Capital stock 36.43M 0.00017M 0.00017M 0.00017M
Retained earnings -3.90701M -0.06251M -0.02712M -0.02381M
Other liab - - - -
Good will - - - -
Other assets - - - -
Cash 0.02M 0.12M 0.00476M 0.06M
Cash and equivalents - - - -
Total current liabilities 2.04M 1.26M 0.71M 0.32M
Current deferred revenue - - - -
Net debt - 1.08M 0.40M 0.24M
Short term debt - - - -
Short long term debt - 1.20M 0.40M 0.30M
Short long term debt total - - - -
Other stockholder equity - - - -
Property plant equipment - - - -
Total current assets 0.02M 0.12M 0.00476M 0.06M
Long term investments - - - -
Net tangible assets - - - -
Short term investments - - - -
Net receivables - - - -
Long term debt - - - -
Inventory - - - -
Accounts payable 1.08M 0.03M 0.00285M 0.00000M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 36.61M - - -
Deferred long term asset charges - - - -
Non current assets total 36.61M 1.10M 0.70M 0.26M
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Investments -33.82982M 0.00000M -
Change to liabilities - - -
Total cashflows from investing activities - - -
Net borrowings - - -
Total cash from financing activities 34.54M 0.12M -0.05743M
Change to operating activities - - -
Net income 0.40M -0.03539M -0.00331M
Change in cash -0.10908M 0.12M -0.05790M
Begin period cash flow 0.12M 0.00476M 0.06M
End period cash flow 0.02M 0.12M 0.00476M
Total cash from operating activities -0.81877M -0.00424M -0.00046M
Issuance of capital stock 63.97M 0.00000M 0.00000M
Depreciation - - -
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory - - -
Change to account receivables - - -
Sale purchase of stock -35.99573M 0.00000M -
Other cashflows from financing activities - - -
Change to netincome - - -
Capital expenditures 0.00000M 0.00000M 0.00000M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital 1.55M 0.03M 0.00285M
Stock based compensation - - -
Other non cash items -2.77529M - -
Free cash flow -0.81877M -0.00424M -0.00046M

Peer Comparison

Sector: Financial Services Industry: Shell Companies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
BLACW
Bellevue Life Sciences Acquisition Corp. Warrant
- -% - - - - -
AGLY
Agiliti Inc
- -% 2.05 - - 487.42 4.19 1814.52 -18211.8716
SVMB
SavMobi Technology Inc.
- -% 11.87 - - 239.23 - 363.28 -319.6012
PBAJ
Petro Usa Inc
- -% 5.00 - - - - -9042.9978
AACT
Ares Acquisition Corporation II
0.01 0.13% 11.29 24.84 - - 1.31

Reports Covered

Stock Research & News

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.